Literature DB >> 18573482

Age-related renal disease in female Dahl salt-sensitive rats is attenuated with 17 beta-estradiol supplementation by modulating nitric oxide synthase expression.

Christine Maric1, Qin Xu, Kathryn Sandberg, Carmen Hinojosa-Laborde.   

Abstract

BACKGROUND: The incidence of chronic renal disease in women increases with aging, especially after menopause, suggesting that loss of sex hormones may contribute to the development and progression of renal disease. However, the mechanisms by which sex hormones, particularly estrogens, contribute to the disease process are unclear.
OBJECTIVE: The present study examined the effects of ovariectomy (OVX) with or without 17 beta-estradiol (E2) supplementation (OVX+E2) on the expression of inducible (iNOS) and endothelial (eNOS) nitric oxide synthase in the kidney.
METHODS: The study was performed in young (4 months [4M]) and aged (12 months [12M]) female Dahl salt-sensitive rats fed a low-sodium (0.1% NaCl) diet. At 3 months of age, the animals were either subjected to sham surgery, OVX, or OVX with implantation of an E2 silastic pellet. The treatments were administered for either 1 or 9 months, rendering the animals 4 months of age or 12 months of age at the time of sacrifice, respectively. Renal expression of NOS isoforms was measured by Western blotting and immunohistochemistry.
RESULTS: OVX in the aged rats was associated with 35% and 25% decreases in medullary iNOS (mean [SEM] relative optical density [ROD]: 4M OVX, 1.81 [0.14] vs 12M OVX, 1.17 [0.16]; P < 0.05) and eNOS (mean ROD: 4M OVX, 1.91 [0.09] vs 12M OVX, 1.43 [0.15]; P < 0.05) protein expression, respectively, and a 25-fold increase in the abundance of CD68-positive cells, indicating macrophage infiltration (mean cells/mm2: 4M OVX, 1.18 [0.09] vs 12M OVX, 30.0 [0.74]; P < 0.001). E2 supplementation either partially or completely attenuated these changes in iNOS (mean ROD: 4M OVX+E2, 2.26 [0.08] vs 12M OVX+E2, 1.70 [0.09]; P < 0.05), eNOS (mean ROD: 4M OVX+E2, 2.03 [0.07] vs 12M OVX+E2, 1.77 [0.11]; P = NS) and CD68 (mean cells/mm2: 4M OVX+E2, 1.46 [0.07] vs 12M OVX+E2, 6.87 [1.6]; P < 0.01) associated with OVX in the aging kidney.
CONCLUSIONS: These data suggest that ovarian E2 loss with aging may contribute to the development of age-related renal disease through downregulation of iNOS and eNOS protein abundance and increased renal inflammation in this animal model. Furthermore, E2 supplementation may be protective in the aging kidney by attenuating these changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573482      PMCID: PMC3177159          DOI: 10.1016/j.genm.2008.05.002

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  24 in total

1.  Role of female sex hormones in the development and reversal of dahl hypertension.

Authors:  C Hinojosa-Laborde; D L Lange; J R Haywood
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

Review 2.  Gender and the progression of renal disease.

Authors:  Joel Neugarten
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

3.  NO synthase uncoupling in the kidney of Dahl S rats: role of dihydrobiopterin.

Authors:  Norman E Taylor; Kristopher G Maier; Richard J Roman; Allen W Cowley
Journal:  Hypertension       Date:  2006-10-23       Impact factor: 10.190

Review 4.  Gender and the progression of renal disease.

Authors:  S L Seliger; C Davis; C Stehman-Breen
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

5.  Blood pressure predicts risk of developing end-stage renal disease in men and women.

Authors:  Masahiko Tozawa; Kunitoshi Iseki; Chiho Iseki; Kozen Kinjo; Yoshiharu Ikemiya; Shuichi Takishita
Journal:  Hypertension       Date:  2003-04-21       Impact factor: 10.190

6.  Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB.

Authors:  Carmen Gómez-Guerrero; Oscar López-Franco; Yusuke Suzuki; Guillermo Sanjuán; Purificación Hernández-Vargas; Julia Blanco; Jesús Egido
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

7.  Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR.

Authors:  N D Vaziri; X Q Wang; Z Ni Ni; S Kivlighn; S Shahinfar
Journal:  Biochim Biophys Acta       Date:  2002-10-21

8.  Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative.

Authors:  S Wassertheil-Smoller; G Anderson; B M Psaty; H R Black; J Manson; N Wong; J Francis; R Grimm; T Kotchen; R Langer; N Lasser
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

9.  Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system.

Authors:  Aaron Erdely; Ziv Greenfeld; Laszlo Wagner; Chris Baylis
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

10.  Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.

Authors:  Lisa M Harrison-Bernard; Ivonne Hernandez Schulman; Leopoldo Raij
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

View more
  14 in total

1.  Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Emma H Trimmer; Shreya N Kashyap; Jennifer L Duong; Brennah Murphy; Elin M Grissom; Jill M Daniel; Sarah H Lindsey
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-09

2.  Renal NOS activity, expression, and localization in male and female spontaneously hypertensive rats.

Authors:  Jennifer C Sullivan; Jennifer L Pardieck; Kelly A Hyndman; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

3.  Hypersensitivity to acute ANG II in female growth-restricted offspring is exacerbated by ovariectomy.

Authors:  Norma B Ojeda; Suttira Intapad; Thomas P Royals; Joshua T Black; John Henry Dasinger; F Lee Tull; Barbara T Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 4.  Yes! Sex matters: sex, the brain and blood pressure.

Authors:  Meredith Hay; Baojian Xue; Alan Kim Johnson
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

5.  Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats.

Authors:  Beth R Santmyire; Vasuki Venkat; Ernst Beinder; Chris Baylis
Journal:  Steroids       Date:  2010-07-07       Impact factor: 2.668

6.  Salt-sensitive (Rapp) rats from Envigo spontaneously develop accelerated hypertension independent of ovariectomy on a low-sodium diet.

Authors:  Amrita V Pai; Crystal A West; Aline M A de Souza; Xi Cheng; David A West; Hong Ji; Xie Wu; Chris Baylis; Kathryn Sandberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-07-19       Impact factor: 3.619

7.  Neuronal nitric oxide synthase inhibition improves diastolic function and reduces oxidative stress in ovariectomized mRen2.Lewis rats.

Authors:  Jewell A Jessup; Lili Zhang; Alex F Chen; Tennille D Presley; Daniel B Kim-Shapiro; Mark C Chappell; Hao Wang; Leanne Groban
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

8.  Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension.

Authors:  Heddwen L Brooks; Meredith Hay; Dennis P Pollow; Jennifer Uhrlaub; Melissa Romero-Aleshire; Kathryn Sandberg; Janko Nikolich-Zugich
Journal:  Hypertension       Date:  2014-06-02       Impact factor: 10.190

9.  Female sex hormones protect against salt-sensitive hypertension but not essential hypertension.

Authors:  Krystal N Brinson; Olga Rafikova; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-15       Impact factor: 3.619

10.  ANG II-induced hypertension in the VCD mouse model of menopause is prevented by estrogen replacement during perimenopause.

Authors:  Dennis P Pollow; Melissa J Romero-Aleshire; Jessica N Sanchez; John P Konhilas; Heddwen L Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.